Alpha Teknova (TKNO) Stock: Buy, Sell, or Hold?
TKNO - Alpha Teknova, Inc. Common Stock
$6.15
0.30 (5.13%)
▲
5d:
-19.08%
30d:
-31.13%
90d:
+23.74%
WAIT
LOW Confidence
Analysis Updated: Oct 22, 2026 12:00 AM ET
Earnings: Nov 05, 2026
12d
Get Alerted When TKNO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: TKNO is down 19.1% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: TKNO is down 19.1% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: TKNO is currently trading at $6.15, which is considered oversold relative to its 30-day fair value range of $7.14 to $9.08.
Technical Outlook: Technically, TKNO is in a strong uptrend. Immediate support is located at $4.94, while resistance sits at $9.04. The stock is showing strong short-term momentum, up 5.1% recently.
Market Sentiment: The stock scores a mixed 48/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $9.67 (+57.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, TKNO is in a strong uptrend. Immediate support is located at $4.94, while resistance sits at $9.04. The stock is showing strong short-term momentum, up 5.1% recently.
Market Sentiment: The stock scores a mixed 48/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $9.67 (+57.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$7.14 -
$9.08
Company Quality Score
48/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
87.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (48/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+5.1%)
- BULLISH: Trading 57.2% below Wall St target ($9.67)
- WARNING: Composite score 48/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$7.14 -
$9.08
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$4.94
Resistance Level
$9.04
Current Trend
Strong Uptrend
Technical data as of
Oct 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-32.37
Wall Street Target
$9.67
(+57.2%)
Revenue Growth (YoY)
18.5%
Profit Margin
-38.4%
Share & Embed Analysis
Last updated: October 23, 2026 9:21 AM ET
Data refreshes hourly during market hours. Next update: 10:21 AM
Data refreshes hourly during market hours. Next update: 10:21 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TKNO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
29 analysts |
$207 | 60 HOLD |
|
ELAN
Elanco Animal Health |
STRONG BUY
16 analysts |
$31 | 49 HOLD |
|
ALKS
Alkermes Plc |
STRONG BUY
19 analysts |
$56 | 43 HOLD |
|
AQST
Aquestive Therapeutics I… |
STRONG BUY
9 analysts |
$9 | 62 BUY |
|
HROW
Harrow Health Inc |
STRONG BUY
9 analysts |
$65 | 59 HOLD |
